4Moving Biotech Appoints Luc Boblet As New Chief Executive Officer
02 Jul 2024 //
BUSINESSWIRE
4Moving Biotech Announces Positive Liraglutide Osteoarthritis Trial Results
10 Jun 2024 //
BUSINESSWIRE
4Moving Bio forms Advisory Board of World-Renowned Knee Osteoarthritis Experts
10 Nov 2023 //
BUSINESSWIRE
4Moving Completes Recruitment of Phase I Trial in Knee Osteoarthritis
19 Oct 2023 //
BUSINESSWIRE